Publications by authors named "Eva Reijmen"

Immune checkpoint blockade (ICB) of the PD-1 pathway revolutionized the survival forecast for advanced non-small cell lung cancer (NSCLC). Yet, the majority of PD-L1 NSCLC patients are refractory to anti-PD-L1 therapy. Recent observations indicate a pivotal role for the PD-L1 tumor-infiltrating myeloid cells in therapy failure.

View Article and Find Full Text PDF
Article Synopsis
  • The combination of radiotherapy (RT) and immunotherapy shows potential for improving treatment outcomes in non-small cell lung cancer (NSCLC) patients, but current response rates are low and require further optimization.
  • In preclinical studies using mice, vagal nerve stimulation (VNS) was tested alone and with RT, revealing that while it didn't significantly impact tumor growth, VNS enhanced the activation of CD8 T cells and altered immune profiles in the tumor environment.
  • Clinical trials involving NSCLC patients indicated that VNS alone did not lead to significant immune changes in the blood, but the findings suggest ongoing research into VNS could help improve response rates to combined RT and immunotherapy treatments.
View Article and Find Full Text PDF

Purpose: The combination of standard-of-care radiation therapy (RT) with immunotherapy is moving to the mainstream of non-small cell lung cancer treatment. Multiple preclinical studies reported on the CD8 T cell stimulating properties of RT, resulting in abscopal therapeutic effects. A literature search demonstrates that most preclinical lung cancer studies applied subcutaneous lung tumor models.

View Article and Find Full Text PDF

Accumulating evidence points to a beneficial effect ofvagus nerve activity in tumor development. The vagus nerve is proposed to slow tumorigenesis because of its anti-inflammatory properties mediated through ACh and the α7nAChR. Since α7nAChRs are widely expressed by many types of immune cells we hypothesized that the vagus nerve affects the tumor microenvironment and anticancer immunity.

View Article and Find Full Text PDF

Molecular surveillance of HRSV in Belgium for 15 consecutive seasons (1996-2011) revealed a shift from a regular 3-yearly cyclic pattern, into a yearly alternating periodicity where HRSV-B is replaced by HRSV-A. Phylogenetic analysis for HRSV-A demonstrated the stable circulation of GA2 and GA5, with GA2 being dominant over GA5 during 5 consecutive seasons (2006-2011). We also identified 2 new genotype specific amino acid mutations of the GA2 genotype (A122 and Q156) and 7 new GA5 genotype specific amino acid mutations (F102, I108, T111, I125, D161, S191 and L217).

View Article and Find Full Text PDF